Alloy Therapeutics, Inc.
also invests · investor profileWaltham, US · Founded 2020 · Delaware corporation · 5 known investors
Find your way into Alloy Therapeutics, Inc.
382 people in our graph share verified history with the Alloy Therapeutics, Inc. team — schools, employers, funds. One of them is your warm intro.
A venture studio embedded within Alloy Therapeutics that partners with academics, entrepreneurs, pharma companies, and VCs to create and develop early-stage drug discovery companies. It gives its portfolio companies access to Alloy's discovery technologies and enabling services, and support in strategy, legal, R&D funding, and partnerships to reach Series A financing.
Founders & leadership
Alloy Therapeutics, Inc. was founded in 2020 by Errik B. Anderson.
Board
Investors · 5
Funding
SEC filings, press & company announcements$186.8M disclosed across 4 rounds · 2021–2026
- $40MSeries EApr 2026Source ↗
▶$30MraisedApr 2026 · 11 investors · BiotechnologyRule 506(b)
- Anthony SunDirector
- Alaa HalawaDirector
- Ulrik NielsenDirector
- Jason CammDirector
- Jason ColomaDirector
- Christian KanadyDirector
- Alex KolicichDirector
- Errik B. AndersonExecutive Officer, Director
- Piotr BobrowiczExecutive Officer, Director
- Logan SnyderDirector
- Offering amount
- $40M
- Amount sold
- $30M
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$41.7MraisedOct 2022 · 13 investors · BiotechnologyRule 506(b)
- Anthony SunDirector
- Alaa HalawaDirector
- Ulrik NielsenDirector
- Piotr BobrowiczExecutive Officer, Director
- Jason CammDirector
- Errik B. AndersonExecutive Officer, Director
- Logan SnyderExecutive Officer, Director
- Fabian HansenDirector
- Alex KolicichDirector
- Jason ColomaDirector
- Offering amount
- $41.7M
- Amount sold
- $41.7M
- Proceeds to insiders
- $1M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$75MraisedApr 2021 · 17 investors · BiotechnologyRule 506(b)
- Piotr BobrowiczExecutive Officer, Director
- Ulrik NielsenDirector
- Jay RosanelliExecutive Officer
- Jason ColomaDirector
- Errik B. AndersonExecutive Officer, Director
- Fabian HansenDirector
- Jason CammDirector
- Alex KolicichDirector
- Logan SnyderExecutive Officer, Director
- Offering amount
- $75M
- Amount sold
- $75M
- Proceeds to insiders
- $1M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
4 people who came through Alloy Therapeutics, Inc. went on to found or lead other companies.
In the news
Frequently asked questions
- What does Alloy Therapeutics, Inc. do?
- A venture studio embedded within Alloy Therapeutics that partners with academics, entrepreneurs, pharma companies, and VCs to create and develop early-stage drug discovery companies. It gives its portfolio companies access to Alloy's discovery technologies and enabling services, and support in strategy, legal, R&D funding, and partnerships to reach Series A financing.
- Who founded Alloy Therapeutics, Inc.?
- Alloy Therapeutics, Inc. was founded by Errik B. Anderson in 2020.
- Who are Alloy Therapeutics, Inc.'s investors?
- Alloy Therapeutics, Inc.'s investors include 82VS, 8VC, JIC Venture Growth Investments, MC Healthcare Ventures, Mission Biocapital.
- How much funding has Alloy Therapeutics, Inc. raised?
- Alloy Therapeutics, Inc. has disclosed $186.8M raised across 4 rounds.
- Where is Alloy Therapeutics, Inc. headquartered?
- Alloy Therapeutics, Inc. is headquartered in Waltham, US.